ZA956797B - Method for preparing influenza virus, antigens obtained and the applications. - Google Patents

Method for preparing influenza virus, antigens obtained and the applications.

Info

Publication number
ZA956797B
ZA956797B ZA9506797A ZA956797A ZA956797B ZA 956797 B ZA956797 B ZA 956797B ZA 9506797 A ZA9506797 A ZA 9506797A ZA 956797 A ZA956797 A ZA 956797A ZA 956797 B ZA956797 B ZA 956797B
Authority
ZA
South Africa
Prior art keywords
applications
influenza virus
antigens obtained
preparing influenza
preparing
Prior art date
Application number
ZA9506797A
Other languages
English (en)
Inventor
Jean-Michel Violay
Guy Court
Catherine Gerdil
Herve Chalumeau
Patrick Mcverry
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of ZA956797B publication Critical patent/ZA956797B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA9506797A 1994-08-16 1995-08-15 Method for preparing influenza virus, antigens obtained and the applications. ZA956797B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410039A FR2723740B1 (fr) 1994-08-16 1994-08-16 Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications

Publications (1)

Publication Number Publication Date
ZA956797B true ZA956797B (en) 1997-02-17

Family

ID=9466323

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506797A ZA956797B (en) 1994-08-16 1995-08-15 Method for preparing influenza virus, antigens obtained and the applications.

Country Status (10)

Country Link
US (1) US6048537A (fr)
EP (1) EP0776362A1 (fr)
JP (1) JPH10504033A (fr)
AU (1) AU701024B2 (fr)
CA (1) CA2197683C (fr)
FR (1) FR2723740B1 (fr)
MX (1) MX9701183A (fr)
NZ (1) NZ288254A (fr)
WO (1) WO1996005294A1 (fr)
ZA (1) ZA956797B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
EP1103610A1 (fr) * 1999-11-26 2001-05-30 Introgene B.V. Production de vaccins de lignées de cellules mammifère immortalisées
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
KR100473070B1 (ko) * 2002-08-31 2005-03-10 박승국 시각적 유도장치를 이용한 외국어 학습 및 교습 시스템
CA2503774C (fr) * 2003-06-20 2007-09-25 Microbix Biosystems Inc. Perfectionnements dans la production de virus
US20080254067A1 (en) * 2004-05-20 2008-10-16 Id Biomedical Corporation Process for the Production of an Influenza Vaccine
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
AR054822A1 (es) 2005-07-07 2007-07-18 Sanofi Pasteur Emulsion inmuno adyuvante
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
JP2009514844A (ja) * 2005-11-04 2009-04-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション
AU2007217450A1 (en) * 2006-02-23 2007-08-30 Ovagen International Limited Improved methods of producing avian eggs and birds of specified germ-free status
EP2139993A2 (fr) * 2007-04-27 2010-01-06 Dow Global Technologies Inc. Production améliorée et assemblage in vivo de particules icosaédriques solubles recombinées analogues à un virus
KR101581228B1 (ko) * 2007-05-04 2015-12-30 백스터 인터내셔널 인코포레이티드 바이러스의 증식을 위한 ２-단계 온도 프로파일
EP2192917B1 (fr) * 2007-08-28 2014-01-29 Baxter International Inc. Procede pour produire des vaccins viraux
TW200936758A (en) * 2007-11-02 2009-09-01 Intervet Int Bv Orthomyxoviridae propagation
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (fr) 2008-03-05 2020-07-21 Pierre Chouvenc Procede de stabilisation d'un adjuvant contenant une composition de vaccin
NZ587798A (en) 2008-03-18 2013-06-28 Novartis Ag Improvements in the preparation of influenza virus vaccine antigens utilising a phosphate buffer
WO2010089339A1 (fr) 2009-02-06 2010-08-12 Glaxosmithkline Biologicals S.A. Nouveau de purification de virus ou d'antigènes viraux par ultracentrifugation sur gradient de densité
JP5823379B2 (ja) * 2009-05-29 2015-11-25 ノバルティス アーゲー インフルエンザウイルスヘマグルチニンについてのアッセイ
CA2773486C (fr) 2009-09-10 2017-10-10 Merial Limited Nouvelles formulations de vaccin a adjuvants contenant une saponine
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
CN103841963B (zh) 2011-08-12 2018-04-24 梅里亚股份有限公司 用于生物产品特别是疫苗的真空辅助保存
FR3025107B1 (fr) 2014-08-29 2018-10-05 Calixar Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
KR20190044052A (ko) 2016-06-17 2019-04-29 메리얼 인코포레이티드 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064232A (en) * 1974-01-14 1977-12-20 Sandoz Ltd. Process for isolating the immunogenic components of influenza viruses
US4000257A (en) * 1975-12-22 1976-12-28 American Cyanamid Company Process for the purification of influenza virus vaccine
US4057626A (en) * 1976-10-08 1977-11-08 Richardson-Merrell Inc. Process for detoxifying influenza B virus
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
DE3014189A1 (de) * 1980-04-14 1981-10-15 Europäisches Laboratorium für Molekularbiologie (EMBL), 6900 Heidelberg Verfahren zur herstellung eines immunogenen membranproteinaggregats von influenza-, parainfluenza- und rhabdo-viren
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4327182A (en) * 1981-01-22 1982-04-27 Connaught Laboratories Incorporated Purification of influenza sub-unit vaccine
FR2671974A1 (fr) * 1991-01-24 1992-07-31 Pasteur Merieux Serums Vacc Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.

Also Published As

Publication number Publication date
FR2723740A1 (fr) 1996-02-23
MX9701183A (es) 1997-05-31
CA2197683A1 (fr) 1996-02-22
EP0776362A1 (fr) 1997-06-04
AU701024B2 (en) 1999-01-21
JPH10504033A (ja) 1998-04-14
US6048537A (en) 2000-04-11
CA2197683C (fr) 2008-12-30
FR2723740B1 (fr) 1996-11-08
NZ288254A (en) 1999-01-28
WO1996005294A1 (fr) 1996-02-22
AU2741295A (en) 1996-03-07

Similar Documents

Publication Publication Date Title
ZA956797B (en) Method for preparing influenza virus, antigens obtained and the applications.
HK1002055A1 (en) Polyepitope vaccines.
EP0665590A3 (fr) Microstructure mécanique, son procédé de fabrication et dispositifs incorporant cette structure.
EP0632099A3 (fr) Organopolysiloxan et méthode pour le préparer.
ZA964710B (en) Novel compounds, the preparation and use thereof.
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
EP0941981A4 (fr) Cyclopentenones, leur procede de preparation et leur utilisation
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
EP0679677A3 (fr) Procédé de préparation d'une résine siloxane durcissable à la chaleur et modifiée par un composé organique et la résine ainsi obtenue.
EP0878541A4 (fr) Antigenes de rotavirus, vaccins et medicaments servant a diagnostiquer l'infection par rotavirus et leurs procedes de preparation
EP0661331A3 (fr) Polymère contenant du silicium, procédé pour sa préparation et monomère.
EP0599159A3 (fr) Alpha-L-Rhamnosidase pour l'obtention de rhamnose, procédé de préparation et d'utilisation.
EP0615964A3 (fr) Céramique en nitrure d'aluminium et procédé de sa fabrication.
EP0978524A4 (fr) Polymere fluore, son procede de preparation et son utilisation
AU6926496A (en) New cyclic guanidines, process for preparing the same and medicaments
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
AU3982995A (en) Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same
EP0622369A3 (fr) 2-Amino-4-quinoléine-dihydropyridine, procédé pour sa préparation et son utilisation.
EP0675137A3 (fr) Glucanes ayant une structure cyclique et procédés pour leur préparation.
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
AU2631895A (en) Fixing device, and method for the manufacture thereof
ITRM950335A0 (it) Procedimento per regoalre le frequenze di riferimento in un sistema dicomunicazioni.
EP0669361A3 (fr) Procédé de préparation de polyhétérosiloxanes.
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use